Recent MNPR News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 12:00:10 PM
- Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr • GlobeNewswire Inc. • 09/12/2024 12:00:00 PM
- Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:07:29 PM
- Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 12:00:13 PM
- Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers • GlobeNewswire Inc. • 08/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:00:10 PM
- Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 12:02:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 12:01:37 PM
- Monopar Therapeutics Announces 1-for-5 Reverse Stock Split • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/22/2024 11:01:16 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/22/2024 11:00:07 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/11/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:01:43 PM
- Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24 • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:08:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 11:30:32 AM
- Monopar and NorthStar Amend & Extend Collaboration • GlobeNewswire Inc. • 06/11/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 12:00:17 PM
- Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting • GlobeNewswire Inc. • 06/10/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:12:38 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM